Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Benchtop LC-MS System

By Drug Discovery Trends Editor | March 10, 2009

Thermo Fisher Scientific introduced its Thermo Scientific Exactive, a benchtop liquid chromatography-mass spectrometry (LC-MS) system designed for high-throughput and high-performance screening and compound identification applications, at Pittcon 2009. The system leverages the company’s proven Orbitrap mass-analyzer technology to provide precise and reliable information.

The system improves laboratory efficiency and throughput by streamlining many of the technical steps that normally require specialized set-up and operation. An intuitive software interface makes the system easy to use in both expert and ‘walk-up’ mode, while ensuring precise mass identification of target compounds over a wide concentration range, according to Thermo Fisher Scientific. While simple to operate, the system sets new standards for LC-MS performance at resolutions of up to 100,000. When combined with excellent single-scan mass accuracy in positive and negative modes, the Exactive system produces accurate, high-throughput screening and compound identification.

The system’s Pathfinder software provides the right workflow for the right analysis, enabling experienced users to tune and optimize the system, develop methods, and perform a wide range of experiments. New users and non-mass spectrometrists can easily follow developed methods to get analytical answers quickly and automatically, according to the company.

Visit Thermo Scientific at Pittcon 2009 at Booth #1432.

www.thermofisher.com


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE